Table 1.
(Statement 1.3): Value of CA 19-9 to differentiate AIP from pancreatic cancer.
| Study | Sample | CA 19-9 cut-off(U/ml) | Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) |
|---|---|---|---|---|---|---|
| Chang et al., 201421 | AIP: 188PDAC: 130CP: 86 | 37 | 84 | 73 | 68 | 86 |
| 85 | 74 | 91 | 87 | 83 | ||
| Van Heerde et al., 201422 | AIP: 33PDAC: 53Other diseases: 145 | 74 | 73 | 74 | – | – |
| Yan et al., 201723 | AIP: 25PDAC: 100 | 306.75 | 56 | 96 | – | – |
AIP: autoimmune pancreatitis. PDAC: pancreatic adenocarcinoma; CP: chronic pancreatitis (other aetiologies than autoimmune).